Moderna, bird flu

Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...
Moderna shares soared Tuesday as investors placed bets that the pharmaceutical giant’s development of an H5N1 bird flu ...